Top of this page
Skip navigation, go straight to the content
| € million | Actual 2009 | Actual 2008 | Actual 2007 |
|---|---|---|---|
| Revenue | 3 116 | 3 601 | 3 626 |
| Net sales | 2 683 | 3 027 | 3 188 |
| Royalty income & fees | 227 | 396 | 294 |
| Other revenue | 206 | 178 | 144 |
| Gross profit | 2 091 | 2 455 | 2 579 |
| Marketing & Selling expenses | - 781 | - 928 | - 1 054 |
| Research & Development expenses | - 674 | - 767 | - 788 |
| General & Administrative expenses | - 189 | - 227 | - 267 |
| Other operating income (expenses) | 6 | - 1 | 10 |
| Recurring EBIT (REBIT) | 453 | 531 | 480 |
| Non recurring income (expenses) | 384 | - 417 | - 136 |
| EBIT (operating profit) | 837 | 113 | 344 |
| Net financial expenses | - 162 | - 156 | - 125 |
| Profit/(loss) before income taxes | 675 | - 43 | 219 |
| Income tax (expenses) credit | - 168 | 30 | - 60 |
| Net profit (after minority interest) | 513 | 42 | 160 |
| Recurring EBITDA | 698 | 733 | 741 |
| € million | 2009 Dec. 31 | 2008 Dec. 31 | 2007 Dec. 31 Restated |
|---|---|---|---|
| Non-current assets | 7 354 | 7 687 | 7 900 |
| Current assets | 1 780 | 1 837 | 1 782 |
| Total assets | 9 134 | 9 524 | 9 682 |
| Shareholders' equity | 4 417 | 4 017 | 4 264 |
| Non-current liabilities | 2 655 | 2 953 | 3 404 |
| Current liabilities | 2 062 | 2 554 | 2 014 |
| Total liabilities and shareholders' equity | 9 134 | 9 524 | 9 682 |
| € million | 2009 | 2008 | 2007 |
|---|---|---|---|
| Net profits (after minority interests) | 513 | 42 | 160 |
| Cash flow from operating activities | 295 | 366 | 490 |
| Cash flow from investing activities | 472 | - 673 | - 201 |
| Cash flow from financing activities | - 735 | 278 | - 766 |
| Change in cash and cash equivalents | 32 | - 10 | - 478 |